Back
Evolent Health Vs. Monopar Therapeutics Industry Stock Comparison
Sell
32
EVH
Evolent Health
Last Price:
$10.10
Seasonality Move:
5.56%
Sell
45
MNPR
Monopar Therapeutics
Last Price:
$39.96
Seasonality Move:
-24.75%
Sell
32
Evolent Health (EVH)
is a Sell
Is Evolent Health a Buy, Sell or Hold?
-
The current Evolent Health [EVH] share price is $10.14. The Score for EVH is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
EVH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $34.37. The Score for MNPR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EVH Stock Price Chart
What is Evolent Health's stock price today?
-
The Evolent Health share price today is $10.14The current trend is relatively stagnant and EVH is experiencing buying pressure, which is a positive indicator for future bullish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $34.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
EVH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.16 | Sell |
Relative Strength Index (14 RSI): | 55.91 | Buy |
Chaikin Money Flow: | 547345 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.04 - 10.24) | Buy |
Bollinger Bands (100): | (8.15 - 17.49) | Sell |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.8 | Sell |
Relative Strength Index (14 RSI): | 50.93 | Buy |
Chaikin Money Flow: | 16181 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.38 - 44.94) | Sell |
Bollinger Bands (100): | (16.76 - 38.26) | Buy |
EVH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.53 | Buy |
20-day SMA: | 9.59 | Buy |
50-day SMA: | 10.23 | Sell |
200-day SMA: | 18.89 | Sell |
8-day EMA: | 9.63 | Buy |
20-day EMA: | 9.62 | Buy |
50-day EMA: | 10.58 | Sell |
200-day EMA: | 17.5 | Sell |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.92 | Buy |
20-day SMA: | 34.11 | Buy |
50-day SMA: | 35.31 | Sell |
200-day SMA: | 15.6 | Buy |
8-day EMA: | 32.1 | Buy |
20-day EMA: | 33.86 | Buy |
50-day EMA: | 33.39 | Buy |
200-day EMA: | 20.23 | Buy |
Evolent Health Earnings Growth & EVH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.22 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.24 per share, and an increase next year of $0.23 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Evolent Health Technical Analysis
Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |